COM:PHIOPHARMA
Phio Pharmaceuticals
- Stock
Last Close
2.53
22/11 21:00
Market Cap
2.61M
Beta: -
Volume Today
14.85K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -20.93M - | -8.80M 57.95% | -10.22M 16.17% | -8.99M 12.02% | -12.45M 38.45% | -7.36M 40.89% | -8.91M 21.03% | -8.79M 1.28% | -13.29M 51.09% | -11.48M 13.60% | -10.83M 5.70% | |
depreciation and amortization | 99K - | 87K 12.12% | 77K 11.49% | 53K 31.17% | 70K 32.08% | 81K 15.71% | 67K 17.28% | 72K 7.46% | 75K 4.17% | 193K 157.33% | 184K 4.66% | |
deferred income tax | -1.62M - | -233K - | -304K 30.47% | |||||||||
stock based compensation | 1.98M - | 1.85M 6.72% | 1.53M 16.85% | 756K 50.75% | 314K 58.47% | 282K 10.19% | 300K 6.38% | 136K 54.67% | 480K 252.94% | 414K 13.75% | 303K 26.81% | |
change in working capital | 286K - | -881K 408.04% | 1.07M 221.00% | 434K 59.29% | -530K 222.12% | -523K 1.32% | -213K 59.27% | -327K 53.52% | 990K 402.75% | -1.26M 226.87% | -122K 90.29% | |
accounts receivables | ||||||||||||
inventory | ||||||||||||
accounts payables | -253K - | 122K 148.22% | 878K 619.67% | -246K 128.02% | -608K 147.15% | 39K 106.41% | 259K 564.10% | -81K 131.27% | -445K 449.38% | 496K 211.46% | -122K 124.60% | |
other working capital | 539K - | -1.00M 286.09% | 188K 118.74% | 680K 261.70% | 78K 88.53% | -562K 820.51% | -472K 16.01% | -246K 47.88% | 1.44M 683.33% | -1.75M 222.09% | 122K 106.96% | |
other non cash items | 12.25M - | -10K 100.08% | 228K 2,380% | -9K 103.95% | 4.71M 52,377.78% | 109K - | 111K 1.83% | 117K 5.41% | 304K 159.83% | -410K 234.87% | ||
net cash provided by operating activities | -6.31M - | -7.76M 22.93% | -7.32M 5.68% | -7.76M 6.05% | -9.51M 22.60% | -7.52M 20.96% | -8.64M 14.96% | -8.80M 1.82% | -11.86M 34.72% | -12.13M 2.29% | -10.75M 11.38% | |
investments in property plant and equipment | -78K - | -95K 21.79% | -57K 40% | -4K 92.98% | -203K 4,975% | -5K 97.54% | -72K 1,340% | -19K 73.61% | -51K 168.42% | -121K 137.25% | -5K 95.87% | |
acquisitions net | 100K - | |||||||||||
purchases of investments | -9M - | -5M 44.44% | -8M 60% | -2M 75% | ||||||||
sales maturities of investments | 6M - | 8M 33.33% | 2.50M 68.75% | 7.50M 200% | ||||||||
other investing activites | -15K - | 12K 180% | -150K - | |||||||||
net cash used for investing activites | -3.09M - | 2.92M 194.31% | -5.56M 290.50% | 5.35M 196.20% | -103K 101.93% | -5K 95.15% | -72K 1,340% | -19K 73.61% | -51K 168.42% | -121K 137.25% | -5K 95.87% | |
debt repayment | -5K - | -61K 1,120% | -9.27M 15,091.80% | -6K - | -27K 350% | |||||||
common stock issued | 15.68M - | 1.95M 87.58% | 9.49M 387.67% | 10.20M 7.46% | 292K 97.14% | 18.72M 6,310.27% | 781K 95.83% | 12.09M 1,447.76% | 19.58M 61.95% | -28K 100.14% | 7.45M 26,714.29% | |
common stock repurchased | 61K - | 31K 49.18% | 2K - | 3K 50% | 1K 66.67% | -15K 1,600% | -1 99.99% | -28 2,700% | ||||
dividends paid | -4.13M - | -209K 94.94% | -1K - | -4.09M 408,600% | ||||||||
other financing activites | -7K - | 4.13M 59,100% | 9.45M 128.69% | -2K - | 102K 5,200% | -3K 102.94% | 8.17M 272,500% | 2.15M 73.75% | 2.03K 99.91% | -39K 2,023.08% | ||
net cash used provided by financing activities | 15.67M - | 1.95M 87.57% | 9.49M 387.67% | 10.20M 7.46% | 292K 97.14% | 18.82M 6,346.23% | 772K 95.90% | 16.13M 1,989.51% | 21.72M 34.66% | -26K 100.12% | 7.41M 28,611.54% | |
effect of forex changes on cash | ||||||||||||
net change in cash | 6.26M - | -2.89M 146.21% | -3.38M 16.76% | 7.79M 330.51% | -9.32M 219.72% | 11.30M 221.16% | -7.95M 170.32% | 7.31M 192.01% | 9.81M 34.24% | -12.28M 225.10% | -3.34M 72.78% | |
cash at beginning of period | 5.13M - | 11.39M 122.16% | 8.50M 25.41% | 5.12M 39.77% | 12.96M 153.20% | 3.63M 71.97% | 14.93M 311.15% | 6.98M 53.22% | 14.29M 104.67% | 24.11M 68.65% | 11.83M 50.92% | |
cash at end of period | 11.39M - | 8.50M 25.41% | 5.12M 39.77% | 12.91M 152.22% | 3.63M 71.87% | 14.93M 311.15% | 6.98M 53.22% | 14.29M 104.67% | 24.11M 68.65% | 11.83M 50.92% | 8.49M 28.24% | |
operating cash flow | -6.31M - | -7.76M 22.93% | -7.32M 5.68% | -7.76M 6.05% | -9.51M 22.60% | -7.52M 20.96% | -8.64M 14.96% | -8.80M 1.82% | -11.86M 34.72% | -12.13M 2.29% | -10.75M 11.38% | |
capital expenditure | -78K - | -95K 21.79% | -57K 40% | -4K 92.98% | -203K 4,975% | -5K 97.54% | -72K 1,340% | -19K 73.61% | -51K 168.42% | -121K 137.25% | -5K 95.87% | |
free cash flow | -6.39M - | -7.85M 22.91% | -7.37M 6.10% | -7.76M 5.29% | -9.72M 25.15% | -7.53M 22.56% | -8.72M 15.84% | -8.82M 1.19% | -11.91M 35.01% | -12.25M 2.86% | -10.75M 12.21% |
All numbers in (except ratios and percentages)